News / Press Releases - June 23, 2022
EUCOPE and MassBio strengthen trans-Atlantic ties through partnership agreement
BRUSSELS & BOSTON – The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE), the European trade body representing small and mid-sized innovative health technology companies, and the Massachusetts Biotechnology Council (MassBio), the association representing the premier global life sciences and healthcare hub, with 1,500+ members, have signed a reciprocal partnership agreement to foster innovation and collaborations in business and research among their members.
Alexander Natz, Secretary-General of EUCOPE, explained that this agreement will “strengthen institutional ties and provide a good opportunity to build bridges between the innovative small and mid-sized companies of EUCOPE with the world’s top biomedical ecosystem.”
Jason Cordeiro, Chief Business Officer, MassBio says, “Signing this agreement between MassBio and EUCOPE is just the start of a formal relationship between two ecosystems that boast incredible emerging and established companies. We look forward to the expanded collaboration that will benefit members here in Massachusetts and in Europe, but more importantly advance the critical health care innovations being developed on both sides of the Atlantic.”
After formalizing the agreement, EUCOPE and MassBio will begin sharing resources, best-practices and participating in various speaking engagements in Europe and Massachusetts.
Since 2008, the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) has been the voice of small to mid-sized health technology companies in Europe. Representing 2600+ innovative biopharmaceutical companies directly or through national associations, EUCOPE advocates for sound public policy that supports innovation, while fostering a community built on a shared purpose: improving and saving the lives of European patients through innovative therapies and medical technology. Learn more at www.eucope.org
MassBio is a not-for-profit organization founded in 1985 that represents and provides services and support for the Massachusetts life sciences industry. MassBio is committed to advancing Massachusetts’ leadership in the life sciences to grow the industry, add value to the healthcare system and improve patient lives. Representing more than 1,100+ biotechnology companies, academic institutions, research hospitals, and service organizations involved in life sciences and healthcare, MassBio works to advance policy and promote education, while providing member programs, events, industry information, and services. Learn more at www.massbio.org